Market Tracker

08/21 5:16pm ET

Novelion Therapeutics Inc (NASDAQ:NVLN)

During the Trading Day
7.44 -0.06 / -0.80%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.44 0.00 / 0.00%
 
Volume: 277.00
No recent news for Novelion Therapeutics Inc.

Today’s Trading

Previous close7.50
Today’s open7.45
Day’s range7.33 - 7.54
Volume50,336
Average volume (3 months)95,283
Market cap$139.9M
Dividend yield--
Data as of 3:59pm ET, 08/21/2017

Growth & Valuation

Earnings growth (last year)-113.18%
Earnings growth (this year)+78.73%
Earnings growth (next 5 years)+74.60%
Revenue growth (last year)--
P/E ratioNM
Price/Sales7.00
Price/Book1.02

Competitors

 Today’s
change
Today’s
% change
CTSOCytosorbents Corp0.000.00%
CDXCChromadex Corp-0.10-3.05%
CDTXCidara Therapeutics ...0.000.00%
NATRNatures Sunshine Pro...+0.10+1.01%
Data as of 4:00pm ET, 08/21/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$13.6M
Annual profit (last year)-$52.9M
Net profit margin-389.49%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mary J. Szela
Chief Financial &
Administrative Officer
Gregory D. Perry
Corporate headquarters
Vancouver, British Columbia

Forecasts